TNF and erythema multiforme: Nevertheless, the treatment approach for immunocompromised patients as used in the present study (identical antibiotic treatment approach as for immunocompetent patients with EM while continuing treatment with a TNF-α inhibitor) should be monitored with regular follow-up visits.